help_outline Skip to main content

News / Articles

Adjuvant Melatonin for the Prevention of Recurrence and Mortality Following Lung Cancer Resection

Dugald Seely et al.  | Published on 4/7/2021
Despite curative intent resection in patients with non-small cell lung cancer (NSCLC), recurrence leading to mortality remains too common. Melatonin has shown promise for the treatment of patients with lung cancer; however, its effect following cancer resection has not been studied. We evaluated if melatonin taken after complete resection reduces lung cancer recurrence and mortality, or impacts quality of life (QOL), symptomatology or immune function. Read more here.

All News / Articles